Last reviewed · How we verify
NCT05006976: NSAC
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
NA trial testing NSAC health only in Musculoskeletal Disorder in 1,180 participants. Participants enrolled and being followed up; not accepting new ones.
12 April 2028
Quick facts
| Lead sponsor | Nordlandssykehuset HF |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 1,180 |
| Start date | 6 September 2021 |
| Primary completion | 12 April 2028 |
| Estimated completion | 12 January 2033 |
| Sites | 5 locations across Norway |
Drugs / interventions tested
- NSAC health only
- NSAC health + MBW
Conditions studied
- Musculoskeletal Disorder — all drugs for Musculoskeletal Disorder →
- Anxiety Disorders — all drugs for Anxiety Disorders →
- Depression — all drugs for Depression →
- Fatigue — all drugs for Fatigue →
Sponsor
Nordlandssykehuset HF
Who can join
23 and older, any sex, with Musculoskeletal Disorder or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Norwegian Sickness Absence Clinic (NSAC) Nudge Study is a naturalistic randomized controlled multicentre trial which aim is to measure the efficacy of nudging clinicians' attention towards patients' motivation for work, barriers for return to work and work environment challenges, on functional recovery as primary outcome, and health outcomes as secondary outcome. Patients will be recruited in five different NSACs across northern Norway. In total 1100 patients will be randomized to two equal probability treatment arms: 1) NSAC with the nudge, and 2) NSAC without the nudge. The nudge is tailored to the individual patient's needs using survey, and the clinicians are presented with a summary of this patient survey prior to consultations highlighting health problems and challenges as reported by the patient in the survey.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Naturalistic trial of nudging patients and clinicians in the Norwegian sickness absence clinics: a study protocol for the NSAC Nudge Study.
Aars NA, Bardal I, Brinchmann B, Mykletun A. · · 2025 · cited 2× · PMID 40032398 · DOI 10.1136/bmjopen-2024-089758 -
Expanding the Focus on Work Factors in an Outpatient Setting: Does a Nudge of Patients and Clinicians have an Effect on Return-to-Work and Benefits? Findings from the NSAC Nudge Multicentre Randomised Controlled Trial.
Bardal I, Aars NAP, Trichet LO, Brandseth OL, et al · · 2025 · cited 1× · PMID 41385138 · DOI 10.1007/s10926-025-10343-x -
Barriers for return to work as an iatrogenic effect of sickness absence: a proposed conceptual framework and questionnaire based on a cross-sectional study.
Myhrer M, Brinchmann B, Trichet L, Aars NA, et al · · 2026 · PMID 41680726 · DOI 10.1186/s12889-026-26584-1
Verify or expand the search:
- PubMed search for NCT05006976
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Nordlandssykehuset HF trials
Trials by the same sponsor.
- NCT06421584 — Evaluating the Role of SURGical TElementoring in Acquisition of Surgical Skills of Laparoscopic Cholecystectomy. SURGTEA · NA · not yet recruiting
- NCT06476158 — Safer Personalised Cancer Treatment Digital Follow-up · NA · recruiting
- NCT06273644 — Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment · NA · recruiting
- NCT05503628 — A Measurement Study of TIS-modNV and AccuGait Force Platform in People With MS · unknown
- NCT04825704 — Bupivacaine in Tonsillectomy · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05006976 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nordlandssykehuset HF
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05006976.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing